AAAAAA

   
Results: 1-19 |
Results: 19
SYNTHESES, STRUCTURES, AND MAGNETIC-PROPERTIES OF METAL(II) PHOSPHATES WITH M(OH)(PO4)(2) - LAYERS (M = NI, CO, MG)
Authors: HAMANAKA N IMOTO H
Citation: N. Hamanaka et H. Imoto, SYNTHESES, STRUCTURES, AND MAGNETIC-PROPERTIES OF METAL(II) PHOSPHATES WITH M(OH)(PO4)(2) - LAYERS (M = NI, CO, MG), Inorganic chemistry, 37(22), 1998, pp. 5844-5850
SYNTHESIS OF STRUCTURAL ANALOGS OF LEUKOTRIENE B-4 AND THEIR RECEPTOR-BINDING ACTIVITY
Authors: KONNO M NAKAE T SAKUYAMA S NISHIZAKI M ODAGAKI Y NAKAI H HAMANAKA N
Citation: M. Konno et al., SYNTHESIS OF STRUCTURAL ANALOGS OF LEUKOTRIENE B-4 AND THEIR RECEPTOR-BINDING ACTIVITY, Bioorganic & medicinal chemistry, 5(8), 1997, pp. 1621-1647
TRISUBSTITUTED BENZENE LEUKOTRIENE B-4 RECEPTOR ANTAGONISTS - SYNTHESIS AND STRUCTURE-ACTIVITY-RELATIONSHIPS
Authors: KONNO M NAKAE T SAKUYAMA S ODAGAKI Y NAKAI H HAMANAKA N
Citation: M. Konno et al., TRISUBSTITUTED BENZENE LEUKOTRIENE B-4 RECEPTOR ANTAGONISTS - SYNTHESIS AND STRUCTURE-ACTIVITY-RELATIONSHIPS, Bioorganic & medicinal chemistry, 5(8), 1997, pp. 1649-1674
AN EFFICIENT METHOD FOR THE SYNTHESIS OF A NOVEL LEUKOTRIENE B-4 RECEPTOR ANTAGONIST, ONO-4057, VIA MICHAEL REACTION OF DIHYDRORESORCINOL
Authors: KONNO M NAKAE T SAKUYAMA S IMAKI K NAKAI H HAMANAKA N
Citation: M. Konno et al., AN EFFICIENT METHOD FOR THE SYNTHESIS OF A NOVEL LEUKOTRIENE B-4 RECEPTOR ANTAGONIST, ONO-4057, VIA MICHAEL REACTION OF DIHYDRORESORCINOL, Synlett, (12), 1997, pp. 1472-1474
DEVELOPMENT OF EPALRESTAT (KINEDAK(R)) - ALDOSE REDUCTASE INHIBITOR
Authors: KAWAMURA M HAMANAKA N
Citation: M. Kawamura et N. Hamanaka, DEVELOPMENT OF EPALRESTAT (KINEDAK(R)) - ALDOSE REDUCTASE INHIBITOR, Yuki Gosei Kagaku Kyokaishi, 55(7), 1997, pp. 651-657
INTERACTION OF MUTAGENIC TRYPTOPHAN PYROLYSATE WITH D(CGATCG)(2) - INTERCALATION MODEL-BASED ON NMR EXPERIMENTS
Authors: MIHARA Y DOI M INOHARA T KAWAMURA M HAMANAKA N ISHIDA T
Citation: Y. Mihara et al., INTERACTION OF MUTAGENIC TRYPTOPHAN PYROLYSATE WITH D(CGATCG)(2) - INTERCALATION MODEL-BASED ON NMR EXPERIMENTS, Biochemical and biophysical research communications, 240(3), 1997, pp. 803-806
NOVEL NONPROSTANOID PROSTACYCLIN (PGI(2)) MIMETICS WITH HETEROCYCLIC MOIETY
Authors: NAGAO Y TAKAHASHI K TORISU K KONDO K HAMANAKA N
Citation: Y. Nagao et al., NOVEL NONPROSTANOID PROSTACYCLIN (PGI(2)) MIMETICS WITH HETEROCYCLIC MOIETY, Heterocycles, 42(2), 1996, pp. 517-523
CORONARY VASOMOTOR RESPONSE TO ACETYLCHOLINE LATE AFTER ANGIOPLASTY
Authors: NISHIJIMA H MENO H HIGASHI H YAMADA K HAMANAKA N TAKESHITA A
Citation: H. Nishijima et al., CORONARY VASOMOTOR RESPONSE TO ACETYLCHOLINE LATE AFTER ANGIOPLASTY, Japanese Circulation Journal, 60(10), 1996, pp. 789-796
MOLECULAR DESIGN OF NOVEL PGI(2) AGONISTS WITHOUT PG SKELETON .4. (VOL 5, PG 1083, 1995)
Authors: HAMANAKA N TAKAHASHI K NAGAO Y TORISU K TOKUMOTO H KONDO K
Citation: N. Hamanaka et al., MOLECULAR DESIGN OF NOVEL PGI(2) AGONISTS WITHOUT PG SKELETON .4. (VOL 5, PG 1083, 1995), Bioorganic & medicinal chemistry letters, 5(18), 1995, pp. 2179-2179
MOLECULAR DESIGN OF NOVEL PGI(2) AGONISTS WITHOUT PG SKELETON .1.
Authors: HAMANAKA N TAKAHASHI K NAGAO Y TORISU K TOKUMOTO H KONDO K
Citation: N. Hamanaka et al., MOLECULAR DESIGN OF NOVEL PGI(2) AGONISTS WITHOUT PG SKELETON .1., Bioorganic & medicinal chemistry letters, 5(10), 1995, pp. 1065-1070
MOLECULAR DESIGN OF NOVEL PGI(2) AGONISTS WITHOUT PG SKELETON .2.
Authors: HAMANAKA N TAKAHASHI K NAGAO Y TORISU K TAKADA H TOKUMOTO H KONDO K
Citation: N. Hamanaka et al., MOLECULAR DESIGN OF NOVEL PGI(2) AGONISTS WITHOUT PG SKELETON .2., Bioorganic & medicinal chemistry letters, 5(10), 1995, pp. 1071-1076
MOLECULAR DESIGN OF NOVEL PGI(2) AGONISTS WITHOUT PG SKELETON .3.
Authors: HAMANAKA N TAKAHASHI K NAGAO Y TORISU K TOKUMOTO H KONDO K
Citation: N. Hamanaka et al., MOLECULAR DESIGN OF NOVEL PGI(2) AGONISTS WITHOUT PG SKELETON .3., Bioorganic & medicinal chemistry letters, 5(10), 1995, pp. 1077-1082
MOLECULAR DESIGN OF NOVEL PGI(2) AGONISTS WITHOUT PG SKELETON .4.
Authors: HAMANAKA N TAKAHASHI K NAGAO Y TORISU K TOKUMOTO H KONDO K
Citation: N. Hamanaka et al., MOLECULAR DESIGN OF NOVEL PGI(2) AGONISTS WITHOUT PG SKELETON .4., Bioorganic & medicinal chemistry letters, 5(10), 1995, pp. 1083-1086
PHARMACOLOGICAL EVALUATION OF COMBINED PGI(2) AGONISTS THROMBOXANE SYNTHASE INHIBITORS .1.
Authors: HAMANAKA N TAKAHASHI K NAGAO Y TORISU K SHIGEOKA S HAMADA S KATO H TOKUMOTO H KONDO K
Citation: N. Hamanaka et al., PHARMACOLOGICAL EVALUATION OF COMBINED PGI(2) AGONISTS THROMBOXANE SYNTHASE INHIBITORS .1., Bioorganic & medicinal chemistry letters, 5(10), 1995, pp. 1087-1090
NEW ORALLY-ACTIVE SERINE-PROTEASE INHIBITORS - STRUCTURAL REQUIREMENTS FOR THEIR GOOD ORAL ACTIVITY
Authors: SENOKUCHI K NAKAI H NAKAYAMA Y ODAGAKI Y SAKAKI K KATO M MARUYAMA T MIYAZAKI T ITO H KAMIYASU K KIM S KAWAMURA M HAMANAKA N
Citation: K. Senokuchi et al., NEW ORALLY-ACTIVE SERINE-PROTEASE INHIBITORS - STRUCTURAL REQUIREMENTS FOR THEIR GOOD ORAL ACTIVITY, Journal of medicinal chemistry, 38(22), 1995, pp. 4508-4517
NEW ORALLY-ACTIVE SERINE-PROTEASE INHIBITORS
Authors: SENOKUCHI K NAKAI H NAKAYAMA Y ODAGAKI Y SAKAKI K KATO M MARUYAMA T MIYAZAKI T ITO H KAMIYASU K KIM S KAWAMURA M HAMANAKA N
Citation: K. Senokuchi et al., NEW ORALLY-ACTIVE SERINE-PROTEASE INHIBITORS, Journal of medicinal chemistry, 38(14), 1995, pp. 2521-2523
UNIQUE BINDING OF A NOVEL SYNTHETIC INHIBITOR, BONYL]PHENYL]-2-METHYL-2-PROPENOY1]-N-ALLYLGLYCINE METHANESULFONATE, TO BOVINE TRYPSIN, REVEALED BY THE CRYSTAL-STRUCTURE OF THE COMPLEX
Authors: ODAGAKI Y NAKAI H SENOKUCHI K KAWAMURA M HAMANAKA N NAKAMURA M TOMOO K ISHIDA T
Citation: Y. Odagaki et al., UNIQUE BINDING OF A NOVEL SYNTHETIC INHIBITOR, BONYL]PHENYL]-2-METHYL-2-PROPENOY1]-N-ALLYLGLYCINE METHANESULFONATE, TO BOVINE TRYPSIN, REVEALED BY THE CRYSTAL-STRUCTURE OF THE COMPLEX, Biochemistry, 34(39), 1995, pp. 12849-12853
APPLICATION OF AN ALPHA-SIDE-CHAIN LENGTH-SPECIFIC MONOCLONAL-ANTIBODY TO IMMUNOAFFINITY PURIFICATION AND ENZYME-IMMUNOASSAY OF 2,3-DINOR-6-KETO-PROSTAGLANDIN F1-ALPHA FROM HUMAN URINE
Authors: HIRAMATSU M HAYASHI Y YAMAMOTO S HAYASHI A SAWADA M HAMANAKA N YAMASHITA K
Citation: M. Hiramatsu et al., APPLICATION OF AN ALPHA-SIDE-CHAIN LENGTH-SPECIFIC MONOCLONAL-ANTIBODY TO IMMUNOAFFINITY PURIFICATION AND ENZYME-IMMUNOASSAY OF 2,3-DINOR-6-KETO-PROSTAGLANDIN F1-ALPHA FROM HUMAN URINE, Prostaglandins, leukotrienes and essential fatty acids, 50(2), 1994, pp. 69-79
SYNTHESIS AND BIOLOGICAL EVALUATION OF (+ --EPIBATIDINE AND THE CONGENERS/
Authors: SENOKUCHI K NAKAI H KAWAMURA M KATSUBE N NONAKA S SAWARAGI H HAMANAKA N
Citation: K. Senokuchi et al., SYNTHESIS AND BIOLOGICAL EVALUATION OF (+ --EPIBATIDINE AND THE CONGENERS/, Synlett, (5), 1994, pp. 343-344
Risultati: 1-19 |